With positive results, Sarepta may have second gene therapy with potential

With positive results, Sarepta may have second gene therapy with potential

With positive early results, Sarepta appears to have a second gene therapy with potential

By ADAM FEUERSTEIN @adamfeuerstein

FEBRUARY 27, 2019

More reads

• With positive early results, Sarepta appears to have a second gene therapy with potential. (STAT Plus)
• Blackstone and Novartis to launch a cardiovascular drug company. (Wall Street Journal)
• Amazon tapped a company veteran to lead its new pharmacy business, including PillPack. (CNBC)
• Did some pharma execs offer misleading testimony to a Senate committee? (STAT Plus)